|
|
Human parvovirus B19 infection in child blood system diseases |
XU Dong-Liang, ZHANG Guo-Cheng, ZHANG Xiao-Fei, QIAN Xin-Hong |
|
|
Abstract No abstract available
|
|
|
|
Cite this article: |
XU Dong-Liang,ZHANG Guo-Cheng,ZHANG Xiao-Fei et al. Human parvovirus B19 infection in child blood system diseases[J]. 中国当代儿科杂志, 2002, 4(3): 211-212.
|
|
|
|
XU Dong-Liang,ZHANG Guo-Cheng,ZHANG Xiao-Fei et al. Human parvovirus B19 infection in child blood system diseases[J]. CJCP, 2002, 4(3): 211-212.
|
URL: |
http://www.zgddek.com/EN/ OR http://www.zgddek.com/EN/Y2002/V4/I3/211 |
[1] |
WU Yuan-Yuan, CAI Sheng-Yang, HUANG Wei, LI Si-Si, LI Wei, DONG Ao. Clinical and laboratory characteristics of juvenile myelomonocytic leukemia[J]. CJCP, 2018, 20(5): 373-377. |
[2] |
CHENG Yan-Qin, ZHAI Xiao-Wen. Clinical application of minimal residual disease detection in childhood acute leukemia[J]. CJCP, 2018, 20(5): 416-420. |
[3] |
ZHANG Wan-Yan, ZHANG Yuan, DONG Nan-Nan, WANG Ying-Chao, SHENG Guang-Yao, XU Xue-Ju, LIU Yu-Feng. Clinical features and prognosis of malignancy-associated hemophagocytic lymphohistiocytosis in children: a clinical analysis of 24 cases[J]. CJCP, 2018, 20(4): 295-297. |
[4] |
CHEN Xiao-Xiao, SHEN Shu-Hong. Research advances in pharmacogenomics of mercaptopurine[J]. CJCP, 2017, 19(9): 1027-1033. |
[5] |
XU Jin-Yun, LUO Jian-Ming. Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia[J]. CJCP, 2017, 19(8): 945-948. |
[6] |
FU Xiao-Yan, XIE Xiao-Tian, ZHAO Yan. Neurocognitive function of children with acute lymphoblastic leukemia and long-term disease-free survival and related influencing factors[J]. CJCP, 2017, 19(8): 899-903. |
[7] |
WANG Ni-Na, YE Qi-Dong. Advances in targeted therapy for childhood acute myeloid leukemia[J]. CJCP, 2017, 19(7): 832-836. |
[8] |
WU Jun, LU Ai-Dong, ZHANG Le-Ping. Clinical characteristics and prognostic analysis of children and adolescents over 10 years of age with acute lymphoblastic leukemia[J]. CJCP, 2017, 19(6): 614-619. |
[9] |
KONG Qing-Lin, AN Xi-Zhou, GUAN Xian-Min, MA Yi-Mei, LI Peng-Fei, LIANG Shao-Yan, HU Yan-Ni, CUI Ying-Hui, YU Jie. Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia[J]. CJCP, 2017, 19(6): 620-626. |
[10] |
CHEN Zai-Sheng, ZHENG Ling, CHEN Yi-Qiao, YANG Jing-Hui, LI Jian. Pathogens of infections in the induction period of childhood acute lymphoblastic leukemia and drug resistance of isolated strains[J]. CJCP, 2017, 19(2): 176-181. |
[11] |
HE Xu, XU Zhi-Liang. Clinical features and pathogenic gene detection of Diamond-Blackfan anemia[J]. CJCP, 2017, 19(2): 171-175. |
[12] |
ZHANG Pei-Fen, FENG Xiao-Qin, WU Cui-Ling, ZHANG Yu-Ming. Clinical features of children with acute lymphoblastic leukemia complicated by pulmonary infection after chemotherapy[J]. CJCP, 2017, 19(12): 1234-1238. |
[13] |
NI Ya-Ru, XU Xiao-Jun, TANG Yong-Min. Progress in clinical studies of chimeric antigen receptor engineered T cells for treatment of childhood cancer[J]. CJCP, 2017, 19(11): 1219-1224. |
[14] |
TANG Xue, GUO Xia. Research progress in Ph-like childhood acute lymphoblastic leukemia[J]. CJCP, 2017, 19(11): 1213-1218. |
[15] |
YE Zhen-Zhen, XUE Fei-Long, DING Wen-Ping, KONG Xiang, SHEN Yi-Na. Oridonin inhibits proliferation of Jurkat cells via the down-regulation of Brg1[J]. CJCP, 2017, 19(11): 1208-1212. |
|
|
|
|